To further investigate the role of dysregulated Wnt signaling in GBMs, we measured canonical Wnt (cWnt) activity levels across QAD-stages in both healthy and tumor lineages using genetic reporters (TCF/Lef-EGFP; “Methods”) (Fig. 5a). The gene discussed is HNF4A; the disease is neoplasm.